Queirolo, P;
Cinquini, M;
Argenziano, G;
Bassetto, F;
Bossi, P;
Boutros, A;
Clemente, C;
Del Vecchio, M;
Pennachioli, E;
Peris, K;
Quaglino, P;
Reali, A;
Zalaudek, I;
Spagnolo, F.
Cutaneous squamous cell carcinoma (CSCC) accounts for ∼20%-25% of all skin tumors. Its precise incidence is often challenging to determine due to limited statistics and its incorporation with mucosal forms. While most cases have a favorable prognosis, challenges arise in patients presenting with locall...
Seth, Rahul;
Agarwala, Sanjiv S;
Messersmith, Hans;
Alluri, Krishna C;
Ascierto, Paolo A;
Atkins, Michael B;
Bollin, Kathryn;
Chacon, Matias;
Davis, Nancy;
Faries, Mark B;
Funchain, Pauline;
Gold, Jason S;
Guild, Samantha;
Gyorki, David E;
Kaur, Varinder;
Khushalani, Nikhil I;
Kirkwood, John M;
McQuade, Jennifer Leigh;
Meyers, Michael O;
Provenzano, Anthony;
Robert, Caroline;
Santinami, Mario;
Sehdev, Amikar;
Sondak, Vernon K;
Spurrier, Gilliosa;
Swami, Umang;
Truong, Thach-Giao;
Tsai, Katy K;
van Akkooi, Alexander;
Weber, Jeffrey.
To provide guidance to clinicians regarding the use of systemic therapy for melanoma.
American Society of Clinical Oncology convened an Expert Panel and conducted an updated systematic review of the literature.
The updated review identified 21 additional randomized trials.
Neoadjuvant pembrolizumab was n...
Next
Evidence-based recommendations on nivolumab (Opdivo) with platinum- and fluoropyrimidine-based chemotherapy for untreated HER2-negative advanced gastric, gastro-oesophageal junction or oesophageal adenocarcinoma in adults.
Commercial arrangement
There is a commercial access agreement for nivolumab...
